Evaluating kidney injury after contrast procedures at Sohag University Hospitals
Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals
This study looks at how often kidney problems happen after patients receive contrast dye during medical procedures at Sohag University Hospitals, especially in those who may be at higher risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Sohag University Academic / other |
| Locations | 2 sites (Sohag and 1 other locations) |
| Trial ID | NCT06965764 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the occurrence of contrast-induced nephropathy (CIN) following intravenous contrast procedures at Sohag University Hospitals. CIN is a significant complication that can lead to acute renal injury, particularly in patients with certain risk factors such as diabetes or pre-existing renal insufficiency. The study aims to assess the incidence of CIN in both inpatients and outpatients aged 18 and older who have undergone these procedures. By analyzing the rise in serum creatinine levels post-contrast exposure, the study seeks to better understand the risk factors associated with CIN.
Who should consider this trial
Good fit: Ideal candidates for this study are inpatients and outpatients aged 18 years and older who have undergone a single intravenous contrast procedure.
Not a fit: Patients under 18 years, those with end-stage renal disease, or those with severe cardiac failure are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify at-risk patients and improve strategies to prevent contrast-induced nephropathy.
How similar studies have performed: Other studies have shown varying success in understanding and preventing contrast-induced nephropathy, making this approach relevant but not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1- Inpatients and outpatients aged 18years and above who underwent single intravenous Contrast procedures. Exclusion criteria: 1. Patients below 18 years, failure to obtain consent. 2. Patients with ESRD/ on maintenance hemodialysis. 3. New-York Heart Association class IV Congestive Cardiac Failure (CCF) or patients with cardiogenic shock . 4. History of hypersensitivity to contrast in the past or exposure to contrast in the last 24-48 hours, 5-nursing/pregnant subjects. 5. Patients with malignancy or other organ failure like decompensated liver cirrhosis
Where this trial is running
Sohag and 1 other locations
- Sohag university hospitals — Sohag, Egypt (Recruiting)
- Sohag university hospitals — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Esraa R Youssef, Resident
- Email: esraa_ragab_post@med.sohag.edu.eg
- Phone: +201121932876
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.